Literature DB >> 15698480

Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.

James L Wofford1, Christopher A Ohl.   

Abstract

BACKGROUND: Pharmaceutical company representatives (PCRs) influence the prescribing habits and professional behaviour of physicians. However, the skills for interacting with PCRs are not taught in the traditional medical school curriculum. We examined whether an innovative, mandatory workshop for third year medical students had immediate effects on knowledge and attitudes regarding interactions with PCRs.
METHODS: Surveys issued before and after the workshop intervention solicited opinions (five point Likert scales) from third year students (n = 75) about the degree of bias in PCR information, the influence of PCRs on prescribing habits, the acceptability of specific gifts, and the educational value of PCR information for both practicing physicians and students. Two faculty members and one PCR led the workshop, which highlighted typical physician-PCR interactions, the use of samples and gifts, the validity and legal boundaries of PCR information, and associated ethical issues. Role plays with the PCR demonstrated appropriate and inappropriate strategies for interacting with PCRs.
RESULTS: The majority of third year students (56%, 42/75) had experienced more than three personal conversations with a PCR about a drug product since starting medical school. Five percent (4/75) claimed no previous personal experience with PCRs. Most students (57.3%, 43/75) were not aware of available guidelines regarding PCR interactions. Twenty-eight percent of students (21/75) thought that none of the named activities/gifts (lunch access, free stethoscope, textbooks, educational CD-ROMS, sporting events) should be restricted, while 24.0% (8/75) thought that students should be restricted only from sporting events. The perceived educational value of PCR information to both practicing physicians and students increased after the workshop intervention from 17.7% to 43.2% (chi square, p = .0001), and 22.1% to 40.5% (p = .0007), respectively. Student perceptions of the degree of bias of PCR information decreased from 84.1% to 72.9% (p = .065), but the perceived degree of influence on prescribing increased (44.2% to 62.1% (p = .02)).
CONCLUSIONS: Students have exposure to PCRs early in their medical training. A single workshop intervention may influence student attitudes toward interactions with PCRs. Students were more likely to acknowledge the educational value of PCR interactions and their impact on prescribing after the workshop intervention.

Entities:  

Mesh:

Year:  2005        PMID: 15698480      PMCID: PMC549188          DOI: 10.1186/1472-6920-5-5

Source DB:  PubMed          Journal:  BMC Med Educ        ISSN: 1472-6920            Impact factor:   2.463


  19 in total

1.  Encounters with pharmaceutical sales representatives among practicing internists.

Authors:  R P Ferguson; E Rhim; W Belizaire; L Egede; K Carter; T Lansdale
Journal:  Am J Med       Date:  1999-08       Impact factor: 4.965

2.  An innovative approach to educating medical students about pharmaceutical promotion.

Authors:  M S Wilkes; J R Hoffman
Journal:  Acad Med       Date:  2001-12       Impact factor: 6.893

3.  Physician-industry relations. Part 1: individual physicians.

Authors:  Susan L Coyle
Journal:  Ann Intern Med       Date:  2002-03-05       Impact factor: 25.391

4.  Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.

Authors:  M A Steinman; M G Shlipak; S J McPhee
Journal:  Am J Med       Date:  2001-05       Impact factor: 4.965

5.  Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.

Authors:  B B McCormick; G Tomlinson; P Brill-Edwards; A S Detsky
Journal:  JAMA       Date:  2001 Oct 24-31       Impact factor: 56.272

6.  Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives.

Authors:  J A Hopper; M W Speece; J L Musial
Journal:  J Gen Intern Med       Date:  1997-10       Impact factor: 5.128

7.  Teaching information mastery: evaluating information provided by pharmaceutical representatives.

Authors:  A F Shaughnessy; D C Slawson; J H Bennett
Journal:  Fam Med       Date:  1995-10       Impact factor: 1.756

8.  The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products.

Authors:  W S Sandberg; R Carlos; E H Sandberg; M F Roizen
Journal:  Acad Med       Date:  1997-10       Impact factor: 6.893

9.  Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.

Authors:  M D Sergeant; P G Hodgetts; M Godwin; D M Walker; P McHenry
Journal:  CMAJ       Date:  1996-11-01       Impact factor: 8.262

10.  Medical professionalism in the new millennium: a physician charter.

Authors: 
Journal:  Ann Intern Med       Date:  2002-02-05       Impact factor: 25.391

View more
  18 in total

Review 1.  Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice.

Authors:  F M Hajjaj; M S Salek; M K A Basra; A Y Finlay
Journal:  J R Soc Med       Date:  2010-05       Impact factor: 5.344

2.  Norwegian medical students' attitudes towards the pharmaceutical industry.

Authors:  Dordi Lea; Olav Spigset; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

3.  Student feedback about The Skeptic Doctor, a module on pharmaceutical promotion.

Authors:  P Ravi Shankar; Kundan K Singh; Rano M Piryani
Journal:  J Educ Eval Health Prof       Date:  2011-11-30

4.  Active Learning to Promote Early and Effective Physician Interaction with Pharmaceutical Industry Marketing Practices.

Authors:  Elan Baskir; Gagani Athauda; Golsheed N Zeiarati; Sanaz B Kashan; Eduardo Camps-Romero; Marin Gillis
Journal:  Med Sci Educ       Date:  2020-04-22

5.  Prescribers and pharmaceutical representatives: why are we still meeting?

Authors:  Melissa A Fischer; Mary Ellen Keough; Joann L Baril; Laura Saccoccio; Kathleen M Mazor; Elissa Ladd; Ann Von Worley; Jerry H Gurwitz
Journal:  J Gen Intern Med       Date:  2009-05-08       Impact factor: 5.128

6.  Reducing corruption in a Mexican medical school: impact assessment across two cross-sectional surveys.

Authors:  Sergio Paredes-Solís; Ascensio Villegas-Arrizón; Robert J Ledogar; Verónica Delabra-Jardón; José Alvarez-Chávez; José Legorreta-Soberanis; Elizabeth Nava-Aguilera; Anne Cockcroft; Neil Andersson
Journal:  BMC Health Serv Res       Date:  2011-12-21       Impact factor: 2.655

7.  Student feedback about the use of role plays in Sparshanam, a medical humanities module.

Authors:  P Ravi Shankar; Rano M Piryani; Kundan K Singh; Bal Man S Karki
Journal:  F1000Res       Date:  2012-12-13

8.  Knowledge, attitude and skills before and after a module on pharmaceutical promotion in a Nepalese medical school.

Authors:  P Ravi Shankar; Kundan K Singh; Rano M Piryani
Journal:  BMC Res Notes       Date:  2012-01-06

Review 9.  Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review.

Authors:  Kirsten E Austad; Jerry Avorn; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2011-05-24       Impact factor: 11.069

10.  Sources of drug information and their influence on the prescribing behaviour of doctors in a teaching hospital in Ibadan, Nigeria.

Authors:  Kazeem Adeola Oshikoya; Ibrahim Oreagba; Olayinka Adeyemi
Journal:  Pan Afr Med J       Date:  2011-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.